An exclusive briefing.
Hosted by both CEOs.
A 45-minute confidential briefing co-hosted by Peter Moeller, CEO of Moeller & Co. Capital, and Fredrik Lindberg, MD, PhD, CEO of Moroxite AB and co-founder & former CEO of Bonesupport — on the team replacing autologous bone harvest in a USD 10 billion spinal fusion market. FDA Breakthrough Device. Q1 2028 first-in-human.
14
Days
04
Hrs
19
Min
07
Sec
FDA
Breakthrough
$10B+
Global market
1.0M
Surgeries / yr
Q1 2028
First-in-human
Reserve your seat
Confidential briefing
Co-hosted by
Two CEOs. One conversation.
Host · I
Peter Moeller
CEO · Moeller & Co. Capital · Zürich
Founder and CEO of the Swiss boutique sourcing Moroxite AB for a select group of family offices and professional investors. Peter opens the briefing and moderates the live Q&A.
Host · II
Fredrik Lindberg
CEO · Moroxite AB · Lund, Sweden
MD, PhD. Co-founder and former CEO of Bonesupport for 12 years — led the company from early R&D through CE-mark, FDA approval, and launch in the US and EU. Presents the science, the clinical roadmap, and answers your questions directly.
Format
Invitation only · 40 seats
Agenda · 45 minutes
- 00:00Welcome — Peter Moeller introduces the mandate
- 05:00The Moroxite platform — presented by Fredrik Lindberg
- 18:00Preclinical evidence and FDA Breakthrough pathway
- 28:00Capital structure, terms, and exit landscape
- 35:00Live Q&A — both CEOs
The buyers are already named.
CG Bio Novosis · acquired for USD 500M, early-stage.
Medtronic
Stryker
Zimmer Biomet
Globus Medical
J&J DePuy
NuVasive
Who attends?+
Family offices, HNW individuals, institutional allocators, and strategic corporates. Each registration is reviewed; we may decline submissions outside the firm's investor mandate.
Will materials be shared?+
Registered attendees receive a 12-page pre-read memo 48 hours before the session. The full data room opens after a brief qualification call.
Is this a solicitation?+
No. The webinar is informational and restricted to professional investors under Swiss FinSA. No commitment is requested or accepted on the call.
What if I cannot attend live?+
A confidential recording is sent to registered attendees within 24 hours. Q&A questions can be submitted in advance through the registration form.
Ready to reserve? Seats close 24 hours before the briefing.
Reserve seat →